Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease - Takeaways - MDSpire

Disruption of Epithelial Barrier Integrity via Altered GILZ/c-Rel/RACK1 Signaling in Inflammatory Bowel Disease

  • By

  • Erica Buoso

  • Mirco Masi

  • Roberta Valeria Limosani

  • Francesca Fagiani

  • Chiara Oliviero

  • Giorgia Colombo

  • Luigi Cari

  • Marco Gentili

  • Eleonora Lusenti

  • Lucrezia Rosati

  • Federica Pisati

  • Alessandra Pasini

  • Marco Vincenzo Lenti

  • Antonio Di Sabatino

  • Claire Louise Mobbs

  • Stefan Przyborski

  • Simona Ronchetti

  • Cristina Travelli

  • Marco Racchi

  • December 18, 2024

  • 0 min

Share

  • 1

    RACK1 expression is significantly decreased in inflammatory bowel disease (IBD), particularly in ulcerative colitis.

  • 2

    GILZ positively correlates with RACK1 expression, and its depletion leads to impaired epithelial barrier integrity.

  • 3

    The RACK1/SRC/E-cadherin regulatory mechanism is altered in IBD, contributing to epithelial barrier disruption.

  • 4

    Dexamethasone treatment restores RACK1 expression and epithelial barrier integrity in IBD models.

  • 5

    The findings suggest that targeting the GILZ/c-Rel/RACK1 pathway could improve therapies for IBD patients unresponsive to glucocorticoids.

Original Source(s)

Related Content